Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTMS for Auditory Hallucinations in Schizophrenia
NCT03762746Phase 3Unknown
- Sponsor
- Dr. Cipto Mangunkusumo Hospital
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Dr. Cipto Mangunkusumo Hospital. Primary endpoints: Hallucinations change at 2 weeks and Source-monitoring ability at 2 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT03762746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762746.